Cargando…
Immunoexpression of P63 and SOX2 in triple-negative breast cancers, Indonesia
Background: Using immunohistochemical stains to target specific breast cancer markers has become indispensable for evaluation of small diagnostic tissue specimens, and therefore novel marker cocktails for specific breast cancers are required. This study was conducted to assess the immunoexpression o...
Autores principales: | Kamarlis, Reno K, Lubis, Muhammad ND, Hernowo, Bethy S, Kar, Azmi S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820604/ https://www.ncbi.nlm.nih.gov/pubmed/29527291 http://dx.doi.org/10.12688/f1000research.12671.2 |
Ejemplares similares
-
Analysis of Mutant Isocitrate Dehydrogenase 1 Immunoexpression, Ki-67 and Programmed Death Ligand 1 in Diffuse Astrocytic Tumours : Study of Single Center in Bandung, Indonesia
por: Bolly, Hendrikus Masang Ban, et al.
Publicado: (2021) -
The Correlation of KRAS Gene Expression and P53 Immunoexpression in Colorectal Adenocarcinoma
por: Rachmawati, Meike, et al.
Publicado: (2019) -
Characterization of apoptosis and autophagy through Bcl-2 and Beclin-1 immunoexpression in gestational trophoblastic disease
por: Wargasetia, Teresa Liliana, et al.
Publicado: (2015) -
Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia
por: Halim, Freda, et al.
Publicado: (2023) -
Programmed death ligand-1 protein expression difference in basal like and non-basal like triple negative breast cancer and its association with disease free survival and overall survival: A systematic review
por: Halim, Freda, et al.
Publicado: (2021)